共查询到19条相似文献，搜索用时 156 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
本刊编辑部 《中国实用内科杂志》2010,(4)
中国工程院院士、首都医科大学附属北京朝阳医院教授翁心植在内科专业方面博深兼备,他在普通内科、寄生虫病学、心血管疾病和呼吸系统疾病诸领域均有创造性贡献。20世纪70年代末他在国内最早倡导控烟工作,还与世界卫生组织及国际非政府控烟组织合作致力于国际控烟运动,被誉为"中国控烟之父"。本刊编辑部就翁教授的奋斗历程及医生培养制度、医生培养的注意事项及医德医风等问题采访了翁教授。 相似文献
12.
13.
Bloomfield GS Kimaiyo S Carter EJ Binanay C Corey GR Einterz RM Tierney WM Velazquez EJ 《American heart journal》2011,(5):842-847
Noncommunicable diseases are rapidly overtaking infectious, perinatal, nutritional, and maternal diseases as the major causes of worldwide death and disability. It is estimated that, within the next 10 to 15 years, the increasing burden of chronic diseases and the aging of the population will expose the world to an unprecedented burden of chronic diseases. Preventing the potential ramifications of a worldwide epidemic of chronic noncommunicable diseases in a sustainable manner requires coordinated, collaborative efforts. Herein, we present our collaboration's strategic plan to understand, treat, and prevent chronic cardiovascular and pulmonary disease (CVPD) in western Kenya, which builds on a 2-decade partnership between academic universities in North America and Kenya, the Academic Model Providing Access to Healthcare. We emphasize the importance of training Kenyan clinician-investigators who will ultimately lead efforts in CVPD care, education, and research. This penultimate aim will be achieved by our 5 main goals. Our goals include creating an administrative core capable of managing operations, develop clinical and clinical research training curricula, enhancing existing technology infrastructure, and implementing relevant research programs. Leveraging a strong international academic partnership with respective expertise in cardiovascular medicine, pulmonary medicine, and medical informatics, we have undertaken to understand and counter CVPD in Kenya by addressing patient care, teaching, and clinical research. 相似文献
14.
The complex nature of interactions between the pulmonary and cardiovascular systems is becoming increasingly appreciated. Pulmonary vascular abnormalities are frequently present in patients with respiratory disorders, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, sarcoidosis, neuromuscular or chest wall disorders, and disorders of ventilatory control including sleep apnea syndromes and obesity hypoventilation syndrome. Pulmonary hypertension, classified as group III in the World Health Organization classification scheme for pulmonary hypertension, may result in severe right ventricular dysfunction caused by lung disease, also known as cor pulmonale. The development of cor pulmonale is generally associated with poorer prognosis and increased death. Systemic manifestations of lung disease, particularly obstructive disorders, are also particularly relevant because they are associated with increased cardiac death and impaired health status. This article will discuss the most common pulmonary diseases and disorders of ventilatory control that cause pulmonary vascular abnormalities and cor pulmonale, with particular concentration on how treatment of these diseases may affect the heart. In addition, the complex nature of cardiac and lung disease will also be explored, particularly with respect to the relationship between chronic obstructive pulmonary disease, systemic inflammation, atherosclerosis, and cardiovascular death, which is currently a very active focus of research. 相似文献
15.
老年糖尿病死亡病例分析 总被引：4，自引：2，他引：4
目的了解老年糖尿病（DM）住院患者的死亡原因及其死亡危险因素。方法以预设表格方式对哈尔滨医科大学附属第二医院老年病房1993年1月1日至2006年12月31日期间住院的老年DM死亡病例进行回顾性调查。结果①老年DM住院患者死亡86例，占全部死亡病例的20．98％，其中以心血管疾病（33．72％）、脑血管疾病（17．44％）、呼吸系统疾病（13.95％）为前3位最主要死因。②在DM与非DM组的比较中，心血管疾病、脑血管疾病、呼吸系统疾病和泌尿系统疾病较非DM组显著增多，肿瘤患者在非DM组明显增多。③DM病程对高血压、心肌梗死、糖尿病肾病（DN）、脑梗死有显著影响。结论DM是增加老年心血管疾病、脑血管疾病、呼吸系统疾病、泌尿系统疾病的发生率和死亡率的一个重要因素。DM的病程增加也大大增加了高血压、心肌梗死、DN、脑梗死的发生率，从而显著增加了老年人的死亡风险。 相似文献
16.
黄芪防治心血管疾病的临床研究 总被引：22，自引：6，他引：22
现代药理学研究发现黄芪能够保护血管内皮细胞、抗动脉硬化,增加心肌收缩力和心排血量.目前广泛应用于治疗冠心病、肺心病、心力衰竭、病毒性心肌炎等心血管疾病.综述了近年来黄芪在心血管疾病中的作用机制及临床观察. 相似文献
17.
众所周知,慢性阻塞性肺疾病是一种常伴随有显著肺外表现的慢性炎症性疾病,心血管疾病风险增加即此类肺外表现之一。慢性阻塞性肺疾病与心血管疾病之间相关机制复杂,吸烟、衰老、缺氧、全身性炎症、氧化应激及用药等多种因素均可能参与其中。现就其潜在关联机制的研究现状予以综述。 相似文献
18.
超重或肥胖与2型糖尿病、高脂血症和高血压等多种心血管危险因素密切相关。但近年的观察研究表明,已确诊心血管疾病的肥胖患者与患相同心血管疾病的正常体重和消瘦患者相比,具有生存优势。早期肥胖悖论研究主要集中于心力衰竭和冠心病,但最近的数据也表明肥胖悖论还涉及其他心血管疾病,如高血压、心房颤动、肺动脉高压和先天性心脏病。尽管许多研究结果都显示出肥胖悖论,然而关于肥胖悖论的依据以及它是否能让肥胖的心血管疾病患者获益,仍存在大量争论。本综述旨在整理支持和反对肥胖悖论的依据,回顾关于心血管疾病肥胖悖论的假定机制和最新证据,并讨论观察性研究中存在的混杂因素和偏见。 相似文献
19.
目的探讨老年患者血浆脑钠素（BNP）水平与心血管疾病的相关关系。方法用放射免疫分析法测定了144例年龄超过75岁老年患者的血浆BNP水平,其中心血管疾病患者82例,慢性阻塞性肺病患者36例,无心肺疾病健康查体者26例。并对患者进行了6个月的随访。结果老年患者即使无心肺疾患,其平均血浆BNP水平高于正常水平（478．3±62．4 vs 100pg／ml）;心血管疾病患者的血浆BNP水平高于慢性阻塞性肺病患者（954．6±89．2 vs 597．1±81．6pg／ml,P〈0．05）;而慢性阻塞性肺病患者的血浆BNP水平高于无心肺疾患患者（597．1±81．6 vs 478．3±62．4pg／ml,P〈0．05）;且急性冠脉综合征患者的血浆BNP水平显著升高（4231．9±112．3 vs 996．6±42．5pg／ml,P〈0．05）。结论老年患者的血浆BNP水平高于正常;血浆BNP水平可以反映心血管疾病的严重程度,尤其是急性心血管事件的发生。 相似文献